NCT03004911

Brief Summary

The purpose of this study is to test the efficacy of a mobile application named ProFibro to promote self-care, and improve symptoms and health-related quality of life in Brazilian patients with fibromyalgia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 29, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

February 14, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 12, 2017

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

June 17, 2019

Completed
Last Updated

June 17, 2019

Status Verified

December 1, 2016

Enrollment Period

10 months

First QC Date

December 21, 2016

Results QC Date

December 4, 2018

Last Update Submit

March 18, 2019

Conditions

Keywords

fibromyalgiamobile applicationself-carequality of life

Outcome Measures

Primary Outcomes (1)

  • Health-related Quality of Life Assessed With the Revised Fibromyalgia Impact Questionnaire

    Minimum value: 0. Maximum value: 100. Higher scores mean worse outcome.

    6 weeks

Secondary Outcomes (5)

  • Number of Painful Areas Assessed With the Widespread Pain Index

    6 weeks

  • Pain Assessed With the Visual Analogue Scale

    6 weeks

  • Severity of Symptoms Assessed With the Symptom Severity Scale

    6 weeks

  • Self-care Agency Assessed With the Appraisal of Self-Care Agency Scale - Revised

    6 weeks

  • Adherence to Mobile Application Assessed by Number of Clicks on the App Functions

    6 weeks

Study Arms (2)

Mobile application

EXPERIMENTAL
Device: ProFibro (Mobile application)

Paper booklet

ACTIVE COMPARATOR
Device: Paper booklet

Interventions

ProFibro, a mobile Android application in Brazilian Portuguese to promote self-care in patients with fibromyalgia

Mobile application

A 64-page booklet with content similar to the mobile application

Paper booklet

Eligibility Criteria

Age19 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • diagnosis of fibromyalgia, according to the 2010 American College of Rheumatology diagnostic criteria
  • smartphone user
  • complete primary education

You may not qualify if:

  • being in physical therapy treatment for fibromyalgia or having been treated in the last 3 months
  • diagnosis of other chronic pain conditions (neuropathies, rheumatoid arthritis, osteoarthritis, spinal stenosis or cancer)
  • severe mental disorders (schizophrenia, psychosis, bipolar affective disorder, severe depression)
  • moderate or severe intellectual disability
  • hearing or visual impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physical Therapy, Speech Therapy and Occupational Therapy of the School of Medicine of the University of Sao Paulo

São Paulo, 05360-160, Brazil

Location

Related Publications (11)

  • Paiva ES, Heymann RE, Rezende MC, Helfenstein M Jr, Martinez JE, Provenza JR, Ranzolin A, de Assis MR, Pasqualin VD, Bennett RM. A Brazilian Portuguese version of the Revised Fibromyalgia Impact Questionnaire (FIQR): a validation study. Clin Rheumatol. 2013 Aug;32(8):1199-206. doi: 10.1007/s10067-013-2259-6. Epub 2013 Apr 21.

    PMID: 23604595BACKGROUND
  • Bennett RM, Bushmakin AG, Cappelleri JC, Zlateva G, Sadosky AB. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol. 2009 Jun;36(6):1304-11. doi: 10.3899/jrheum.081090. Epub 2009 Apr 15.

    PMID: 19369473BACKGROUND
  • Altman DG, Bland JM. How to randomise. BMJ. 1999 Sep 11;319(7211):703-4. doi: 10.1136/bmj.319.7211.703. No abstract available.

    PMID: 10480833BACKGROUND
  • Henriksson C, Carlberg U, Kjallman M, Lundberg G, Henriksson KG. Evaluation of four outpatient educational programmes for patients with longstanding fibromyalgia. J Rehabil Med. 2004 Sep;36(5):211-9. doi: 10.1080/16501970410027494.

    PMID: 15626161BACKGROUND
  • Nam S, Tin D, Bain L, Thorne JC, Ginsburg L. Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an outpatient fibromyalgia education program. Clin Rheumatol. 2014 May;33(5):685-92. doi: 10.1007/s10067-013-2377-1. Epub 2013 Sep 1.

    PMID: 23995734BACKGROUND
  • Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120. doi: 10.1186/ar2783. Epub 2009 Aug 10.

    PMID: 19664287BACKGROUND
  • Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S154-62.

    PMID: 16273800BACKGROUND
  • Marques AP, Assumpcao A, Matsutani LA, Pereira CA, Lage L. Pain in fibromyalgia and discrimination power of the instruments: Visual Analog Scale, Dolorimetry and the McGill Pain Questionnaire. Acta Reumatol Port. 2008 Jul-Sep;33(3):345-51.

    PMID: 18846013BACKGROUND
  • Sousa VD, Zauszniewski JA, Bergquist-Beringer S, Musil CM, Neese JB, Jaber AF. Reliability, validity and factor structure of the Appraisal of Self-Care Agency Scale-Revised (ASAS-R). J Eval Clin Pract. 2010 Dec;16(6):1031-40. doi: 10.1111/j.1365-2753.2009.01242.x.

    PMID: 20626539BACKGROUND
  • Damasio BF, Koller SH. The Appraisal of Self-Care Agency Scale - Revised (ASAS-R): adaptation and construct validity in the Brazilian context. Cad Saude Publica. 2013 Oct;29(10):2071-82. doi: 10.1590/0102-311x00165312.

    PMID: 24127101BACKGROUND
  • Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010 May;62(5):600-10. doi: 10.1002/acr.20140.

    PMID: 20461783BACKGROUND

Related Links

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Results Point of Contact

Title
Amélia Pasqual Marques
Organization
School of Medicine at the University of Sao Paulo

Study Officials

  • Susan LK Yuan, MSc

    Rehabilitation Sciences PhD program of the School of Medicine of the University of Sao Paulo

    PRINCIPAL INVESTIGATOR
  • Amelia P Marques, PhD

    Department of Physical Therapy, Speech Therapy and Occupational Therapy of the School of Medicine of the University of Sao Paulo

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2016

First Posted

December 29, 2016

Study Start

February 14, 2017

Primary Completion

December 12, 2017

Study Completion

December 12, 2017

Last Updated

June 17, 2019

Results First Posted

June 17, 2019

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations